Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-032789

G1 Therapeutics, Inc. · GTHX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Clay Thorp
10% Owner
John Crumpler
10% Owner
Period of report
May 21, 2018
Accepted (ET)
May 23, 2018 · 8:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001560241

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4May 21, 2018S29,005$51.1604D4,046,206ISee Footnotes
Common StockF1,F2,F4,F5May 21, 2018S1,595$51.0589D4,044,611ISee Footnotes
Common StockF6,F4,F5,F7May 21, 2018S474$52.13D4,044,137ISee Footnotes
Common StockF6,F4,F7,F8May 21, 2018S26$52.13D4,044,111ISee Footnotes
Common StockF9,F4,F8,F10May 22, 2018S5,592$50.8593D4,038,519ISee Footnotes
Common StockF9,F4,F10,F11May 22, 2018S308$50.6851D4,038,211ISee Footnotes
Common StockF4,F11,F12May 23, 2018S474$50.50D4,037,737ISee Footnotes
Common StockF4,F12,F13May 23, 2018S26$50.50D4,037,711ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses